MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 4 filers reported holding MARINUS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $265,000 | +147.7% | 104,300 | +97.2% | 0.00% | – |
| Q1 2020 | $107,000 | +98.1% | 52,900 | +110.8% | 0.00% | – |
| Q4 2019 | $54,000 | +38.5% | 25,100 | 0.0% | 0.00% | – |
| Q3 2019 | $39,000 | -62.5% | 25,100 | 0.0% | 0.00% | – |
| Q2 2019 | $104,000 | +55.2% | 25,100 | +55.9% | 0.00% | – |
| Q1 2019 | $67,000 | -17.3% | 16,100 | -42.9% | 0.00% | – |
| Q4 2018 | $81,000 | -71.3% | 28,200 | 0.0% | 0.00% | – |
| Q3 2018 | $282,000 | +91.8% | 28,200 | +35.6% | 0.00% | – |
| Q2 2018 | $147,000 | – | 20,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 5,042,735 | $14,473,000 | 4.95% |
| VHCP Management III, LLC | 1,258,964 | $3,613,000 | 2.63% |
| Granite Point Capital Management, L.P. | 2,659,367 | $7,632,000 | 1.54% |
| Granite Point Capital Management, L.P. | 1,600,000 | $4,592,000 | 0.93% |
| VHCP Management II, LLC | 743,876 | $2,135,000 | 0.92% |
| Monashee Investment Management LLC | 250,000 | $718,000 | 0.49% |
| 683 Capital Management, LLC | 1,350,000 | $3,875,000 | 0.24% |
| CAXTON CORP | 61,443 | $176,000 | 0.21% |
| Tekla Capital Management LLC | 755,776 | $2,169,000 | 0.09% |
| Fosun International Ltd | 491,997 | $1,378,000 | 0.08% |